ArticleJournal of diabetes research2025
Early Neuropathy as a Predictor of Subclinical Diabetic Nephropathy in Well-Controlled Type 2 Diabetic Patients: A Cross-Sectional Study.
Article in Journal of diabetes research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuropathy predicts early renal impairment in diabetes mellitus-the almost forgotten historical evidence. In memoriam Professor Göran Sundkvist.Frontiers in clinical diabetes and healthcare · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic neuropathy (DN) and nephropathy (DKD) are prevalent microvascular complications in Type 2 diabetes mellitus (T2DM), often evolving silently. Detecting early nephropathy remains a clinical challenge, especially in patients with preserved renal function. Objective: The objective was to determine whether the Toronto Clinical Scoring System (TCS) for diabetic neuropathy can predict early nephropathy (albuminuria) in people with well-controlled T2DM who have a normal eGFR. Methods: We conducted a cross-sectional study with 122 T2DM patients (HbA1c < 7%, eGFR > 90) to look for peripheral neuropathy using TCS and nephropathy using the urinary albumin-to-creatinine ratio (UACR). Patients were classified based on the presence of albuminuria (UACR ≥ 30 mg/g). Statistical analyses included Results: Patients with diabetic nephropathy or neuropathy were significantly older and exhibited higher systolic blood pressure and albuminuria. A clear stepwise increase in albuminuria was observed with rising neuropathy severity, with nephropathy prevalence ranging from 42% in patients without neuropathy to 72% in those with severe neuropathy. A significant positive correlation between TCS and UACR ( Conclusion: Clinical diabetic neuropathy is significantly associated with early nephropathy in well-controlled T2DM patients. Routine neuropathy assessment may serve as a simple, cost-effective predictor of subclinical renal damage. Future prospective studies should investigate whether early intervention in patients with neuropathy can attenuate or delay renal injury and whether this predictive link holds true across diverse ethnic and age groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.